BOSTON – Legislation filed by Senator Michael O. Moore (D-Millbury) would officially recognize the month of May as “Cystic Fibrosis Awareness Month.” After receiving a favorable report by the Joint Committee on State Administration and Regulatory Oversight, the bill recently received unanimous approval in the Senate.
Cystic fibrosis is a genetic disease that affects around 30,000 people in the United States. It is characterized by persistent coughing, blocked lungs, frequent lung infections, wheezing and shortness of breath. According to the Cystic Fibrosis Patient Registry, approximately 1,000 new cases of cystic fibrosis are diagnosed each year, with over 75 percent of those diagnoses occurring in patients under 2 years of age. With advancements in treatment and care options, those with cystic fibrosis are often able to live well into adulthood.
“By declaring May as Cystic Fibrosis Awareness Month, we hope to highlight the disease and to encourage opportunities for enhanced research and better treatment options for local residents,” said Senator Moore. “Massachusetts would stand together with the Cystic Fibrosis Foundation and local organizations in showing support for patients living with this serious condition.”
The month of May also coincides with the Cystic Fibrosis Foundation’s National Awareness Month. The Moore-sponsored legislation has now been referred to the House of Representatives for consideration. To continue tracking the bill, S.2137, please click below.